Back to today’s briefing

Story perspectives

Hair-Loss Anxiety Stops One-Third of Trans Men from Starting Testosterone

7/9/2026

27 4 Full Breakdown

Summary

Story summary

Hair-loss anxiety deters many transmasculine people from scheduling testosterone hormone therapy appointments.
A 2021 study found that 33 % of trans people on testosterone experience androgenic hair thinning.
Finasteride, an oral DHT blocker, reduces hair loss but may also slow facial and body-hair growth.
Minoxidil, a topical treatment approved by the FDA for trans patients, improves scalp blood flow to combat hair loss.

1 of 1

Story summary

Hair-loss anxiety deters many transmasculine people from scheduling testosterone hormone therapy appointments.
A 2021 study found that 33 % of trans people on testosterone experience androgenic hair thinning.
Finasteride, an oral DHT blocker, reduces hair loss but may also slow facial and body-hair growth.
Minoxidil, a topical treatment approved by the FDA for trans patients, improves scalp blood flow to combat hair loss.